Table 4.
EORTC QLQ-C30 | SRT (n = 51) |
SRT-delay (n = 57) |
LRT-delay (n = 61) |
P |
---|---|---|---|---|
Mean scale score (s.d.) | Mean scale score (s.d.) | Mean scale score (s.d.) | ||
Global health status | 75 (19) | 71(23) | 71(21) | 0.494 |
Functional scales | ||||
Physical functioning | 86 (19) | 85 (19) | 84 (18) | 0.851 |
Role functioning | 81 (28) | 82 (27) | 79 (27) | 0.868 |
Emotional functioning | 86 (19) | 82 (19) | 84 (19) | 0.525 |
Cognitive functioning | 88 (16) | 85 (17) | 91 (17) | 0.698 |
Social functioning | 74 (28) | 76 (29) | 76 (29) | 0.905 |
Symptoms | ||||
Fatigue | 21 (21) | 24 (23) | 24 (24) | 0.626 |
Nausea and vomiting | 6 (12) | 6 (16) | 2 (7) | 0.091 |
Pain | 19 (26) | 19 (26) | 17 (26) | 0.812 |
Single items | ||||
Dyspnoea | 16 (22) | 19 (24) | 19 (25) | 0.714 |
Insomnia | 20 (25) | 21 (29) | 21 (29) | 0.963 |
Appetite loss | 5 (12) | 6 (18) | 10 (24) | 0.397 |
Constipation | 17 (27) | 14 (24) | 15 (29) | 0.791 |
Diarrhoea | 23 (30) | 22 (31) | 19 (30) | 0.752 |
Financial difficulties | 2 (11) | 10 (23) | 9 (20) | 0.074 |
EORTC, European Organization for Research and Treatment of Cancer; QLQ-C30, Quality of Life Core Questionnaire C30, version 3.0; SRT, short-course radiotherapy and surgery within 1 week; SRT-delay, short-course radiotherapy, with surgery after 4–8 weeks; LRT-delay, long-course radiotherapy of 25 × 2 Gy, with surgery after 4–8 weeks.